These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19012633)

  • 21. Meta-analysis of suicide-related behavior events in patients treated with atomoxetine.
    Bangs ME; Tauscher-Wisniewski S; Polzer J; Zhang S; Acharya N; Desaiah D; Trzepacz PT; Allen AJ
    J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):209-218. PubMed ID: 18176331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute atomoxetine effects on the EEG of children with attention-deficit/hyperactivity disorder.
    Barry RJ; Clarke AR; Hajos M; McCarthy R; Selikowitz M; Bruggemann JM
    Neuropharmacology; 2009 Dec; 57(7-8):702-7. PubMed ID: 19698723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
    Newcorn JH; Kratochvil CJ; Allen AJ; Casat CD; Ruff DD; Moore RJ; Michelson D;
    Am J Psychiatry; 2008 Jun; 165(6):721-30. PubMed ID: 18281409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An 18-year-old woman with new-onset suicidal ideation while being treated with atomoxetine.
    Markx S; Kahn DA
    J Psychiatr Pract; 2008 Jan; 14(1):62-6. PubMed ID: 18212605
    [No Abstract]   [Full Text] [Related]  

  • 25. Suboptimal dosing of Strattera (atomoxetine) for ADHD patients.
    Clemow DB
    Postgrad Med; 2014 Sep; 126(5):196-8. PubMed ID: 25420287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.
    ; Bangs ME; Emslie GJ; Spencer TJ; Ramsey JL; Carlson C; Bartky EJ; Busner J; Duesenberg DA; Harshawat P; Kaplan SL; Quintana H; Allen AJ; Sumner CR
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):407-20. PubMed ID: 17822337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of severe akathisia with atomoxetine.
    Baweja R; Petrovic-Dovat L
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):426-7. PubMed ID: 23952192
    [No Abstract]   [Full Text] [Related]  

  • 28. Persistent camptocormia associated with atomoxetine in a child with attention-deficit/hyperactivity disorder.
    Bhattacharya A; Praharaj SK; Sinha VK
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):596-7. PubMed ID: 25469421
    [No Abstract]   [Full Text] [Related]  

  • 29. Atomoxetine-induced electrocardiogram changes.
    Rajesh AS; Bates G; Wright JG
    Arch Dis Child; 2006 Dec; 91(12):1023-4. PubMed ID: 17119076
    [No Abstract]   [Full Text] [Related]  

  • 30. Atomoxetine-induced myocardial infarction.
    Seifi A; Griffith H; Avestimehr S; Dib H
    South Med J; 2011 Feb; 104(2):153-4. PubMed ID: 21206410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Worsening of bruxism with atomoxetine: a case report.
    Mendhekar D; Lohia D
    World J Biol Psychiatry; 2009; 10(4 Pt 2):671-2. PubMed ID: 19165653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atomoxetine-induced mania-like symptoms in an adolescent patient.
    Bahali K; Uneri OS; Ipek H
    Actas Esp Psiquiatr; 2013; 41(2):137-8. PubMed ID: 23592075
    [No Abstract]   [Full Text] [Related]  

  • 33. Atomoxetine.
    Unni JC
    Indian Pediatr; 2006 Jul; 43(7):603-6. PubMed ID: 16891679
    [No Abstract]   [Full Text] [Related]  

  • 34. Drugs for treatment of ADHD.
    Treat Guidel Med Lett; 2006 Nov; 4(51):77-82. PubMed ID: 17039210
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute urinary retention associated with atomoxetine use.
    Desarkar P; Sinha VK
    Aust N Z J Psychiatry; 2006 Oct; 40(10):936. PubMed ID: 16959021
    [No Abstract]   [Full Text] [Related]  

  • 36. First case of sialolithiasis associated with atomoxetine.
    Jerome L; Gardner D; Kutcher SP
    J Clin Psychopharmacol; 2007 Feb; 27(1):111-2. PubMed ID: 17224735
    [No Abstract]   [Full Text] [Related]  

  • 37. Suicidal ideation among children taking atomoxetine (Strattera).
    Wooltorton E
    CMAJ; 2005 Dec; 173(12):1447. PubMed ID: 16330634
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of parent and teacher reports of attention-deficit/hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children.
    Biederman J; Gao H; Rogers AK; Spencer TJ
    Biol Psychiatry; 2006 Nov; 60(10):1106-10. PubMed ID: 16806096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
    Harpin VA
    Arch Dis Child Educ Pract Ed; 2008 Apr; 93(2):58-65. PubMed ID: 18356307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine.
    Wernicke JF; Holdridge KC; Jin L; Edison T; Zhang S; Bangs ME; Allen AJ; Ball S; Dunn D
    Dev Med Child Neurol; 2007 Jul; 49(7):498-502. PubMed ID: 17593120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.